↑ Rising
Business
Kodiak Sciences stock soars on positive AMD trial data
Kodiak Sciences shares surged over 90% following positive Phase 3 trial results for an eye disease drug targeting AMD.
1 trends tracked about this subject — the full history, oldest to newest below.
Kodiak Sciences shares surged over 90% following positive Phase 3 trial results for an eye disease drug targeting AMD.